Look At Analyst Expectations For A Better Read On Roivant Sciences Ltd (NASDAQ: ROIV)
Currently, there are 806.68M common shares owned by the public and among those 377.26M shares have been available to trade. The company’s stock has a 5-day price change of -2.84% and -4.07% over the past three months. ROIV shares are trading 0.71% year to date (YTD), with the 12-month market performance up to 26.09% higher. […]
Look At Analyst Expectations For A Better Read On Roivant Sciences Ltd (NASDAQ: ROIV)
Currently, there are 806.68M common shares owned by the public and among those 376.16M shares have been available to trade. The company’s stock has a 5-day price change of -0.17% and 1.84% over the past three months. ROIV shares are trading 3.65% year to date (YTD), with the 12-month market performance up to 32.12% higher. […]
Value Hunters: Look To Roivant Sciences Ltd (ROIV)
Currently, there are 806.68M common shares owned by the public and among those 376.16M shares have been available to trade. The company’s stock has a 5-day price change of -1.28% and 6.73% over the past three months. ROIV shares are trading 3.12% year to date (YTD), with the 12-month market performance up to 38.19% higher. […]
Investors Should Take Note Of Roivant Sciences Ltd (ROIV)
Roivant Sciences Ltd (ROIV) concluded trading on Wednesday at a closing price of $11.62, with 4.1 million shares of worth about $47.66 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 6.61% during that period and on October 23, 2024 the price saw a […]
Roivant Sciences Ltd (NASDAQ: ROIV): Stock That Needs Special Handling
Currently, there are 806.68M common shares owned by the public and among those 376.18M shares have been available to trade. The company’s stock has a 5-day price change of 5.32% and 5.60% over the past three months. ROIV shares are trading 5.79% year to date (YTD), with the 12-month market performance up to 17.86% higher. […]
Analyst Expect Big Moves From Roivant Sciences Ltd (NASDAQ: ROIV)
Currently, there are 806.68M common shares owned by the public and among those 376.18M shares have been available to trade. The company’s stock has a 5-day price change of -0.79% and 0.27% over the past three months. ROIV shares are trading 0.45% year to date (YTD), with the 12-month market performance up to 4.44% higher. […]
Uncovering Institutional Buying In Roivant Sciences Ltd (NASDAQ: ROIV)
Currently, there are 806.68M common shares owned by the public and among those 376.18M shares have been available to trade. The company’s stock has a 5-day price change of -2.74% and 7.67% over the past three months. ROIV shares are trading 1.25% year to date (YTD), with the 12-month market performance down to -2.65% lower. […]
Set Your Sights On Roivant Sciences Ltd (NASDAQ: ROIV)’S Upside Potential
Roivant Sciences Ltd (ROIV) concluded trading on Thursady at a closing price of $11.36, with 5.08 million shares of worth about $57.69 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 1.88% during that period and on Thursady the price saw a loss of […]
Is Roivant Sciences Ltd (NASDAQ: ROIV) Back In The Buying Zone?
Currently, there are 760.14M common shares owned by the public and among those 478.44M shares have been available to trade. However, the script later moved the day high at 10.90, up 0.56%. The company’s stock has a 5-day price change of 8.48% and 27.13% over the past three months. ROIV shares are trading -3.21% year […]
Roivant Sciences Ltd (NASDAQ: ROIV) Not A Good Play Anymore?
Roivant Sciences Ltd (ROIV) concluded trading on Wednesday at a closing price of $10.39, with 4.64 million shares of worth about $48.18 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -8.78% during that period and on Wednesday February 7 the price saw a […]
